PHARMACOLOGICAL CHARACTERISTICS OF THE STEREOISOMERS OF CARVEDILOL

被引:77
作者
BARTSCH, W [1 ]
SPONER, G [1 ]
STREIN, K [1 ]
MULLERBECKMANN, B [1 ]
KLING, L [1 ]
BOHM, E [1 ]
MARTIN, U [1 ]
BORBE, HO [1 ]
机构
[1] ASTA PHARMA AG,DEPT BIOCHEM,FRANKFURT,GERMANY
关键词
α-blockade; β-blockade; carvedilol; stereoisomers;
D O I
10.1007/BF01409475
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The racemic compound carvedilol possesses two complementary pharmacological effects, vasodilation and β-blockade. The R- and S-enantiomers of carvedilol and the racemate were investigated with respect to the β-blocking, vasodilating, and hypotensive actions. In agreement with results obtained with other β-blockers, only the S-enantiomer of carvedilol exerts β-blocking effects. In contrast, no substantial difference between the enantiomers could be seen with respect to α-blockade. The greater hypotensive activity of S-carvedilol may be attributed to β-blockade, which inhibits counter-regulatory mechanisms provoked by vasodilation. From these results it is concluded that there is a rationale for using carvedilol as the racemate. Using the S-enantiomer would lead to relatively strong β-blockade with only a weak vasodilating effect. The R-enantiomer alone would act only as a hypotensive agent without β-blockade. © 1990 Springer-Verlag.
引用
收藏
页码:S104 / S107
页数:4
相关论文
共 13 条
[1]  
ALMIRANTE L, 1966, J MED CHEM, V9, P620
[2]   STEREOCHEMISTRY, A BASIS FOR SOPHISTICATED NONSENSE IN PHARMACOKINETICS AND CLINICAL-PHARMACOLOGY [J].
ARIENS, EJ .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (06) :663-668
[3]  
ARIENS EJ, 1983, STREOCHEMISTRY BIOL
[4]  
ARUHNLAKSHANA O, 1958, BRIT J PHARMACOL, V14, P48
[5]   BIOLOGICAL PROPERTIES OF OPTICAL ISOMERS OF PROPRANOLOL AND THEIR EFFECTS ON CARDIAC ARRHYTHMIAS [J].
BARRETT, AM ;
CULLUM, VA .
BRITISH JOURNAL OF PHARMACOLOGY, 1968, 34 (01) :43-+
[6]  
Eggertsen R, 1984, J Hypertens, V2, P529, DOI 10.1097/00004872-198410000-00013
[7]  
NAGAKAWA Y, 1990, EUR J CLIN PHARM S2, V38, P115
[8]  
Neugebauer G, 1990, EUR J CLIN PHARMACOL, V38, P108
[9]  
SHIPLEY RE, 1947, P SOC EXP BIOL MED, V64, P453
[10]  
SPONER G, 1987, Journal of Cardiovascular Pharmacology, V10, pS42, DOI 10.1097/00005344-198710110-00007